CD226 Protein (CD226) (His-Avi Tag,Biotin)
Kurzübersicht für CD226 Protein (CD226) (His-Avi Tag,Biotin) (ABIN7865778)
Target
Alle CD226 Proteine anzeigenProtein-Typ
Spezies
Quelle
Reinheit
-
-
Aufreinigungstag / Konjugat
- Dieses CD226 Protein ist gelabelt mit His-Avi Tag,Biotin.
-
Verwendungszweck
- Biotinylated Human DNAM-1/CD226 Protein Recombinant
-
Sequenz
- Glu19-Asn247
-
Produktmerkmale
-
Protein Size: Recombinant Human DNAM-1/CD226 is a protein consisting of amino acid residues [Glu19-Asn247] ,The protein has a predicted MW of 28.9 kDa. Due to glycosylation, the protein migrates to 50-70 kDa based on Tris-Bis PAGE result..
Sequence Position: DNA sequence encoding Human DNAM-1/CD226 including a C-His-Avi tag was expressed in HEK293 Cells. The recombinant protein was then biotinylated site specific using the AVItag biotinylation technology.
-
Sterilität
- 0.22 μm filtered
-
Endotoxin-Niveau
- Endotoxin content was assayed using a LAL gel clot method. Endotoxin level was found to be less than 0.1 ng/μg(1EU/μg).
-
-
Möchten Sie weitere Optionen für dieses Protein ?
!Entdecken Sie unsere vordefinierten maßgeschneiderten Proteine und Proteinservices!Ihr Projekt erfordert weitere Anpassungen? Kontaktieren Sie uns und entdecken Sie unsere maßgeschneiderten Proteinlösungen
-
-
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Centrifuge vial to ensure maximal product extraction, recommended:20sec, 5K RPM
-
Buffer
- Lyophilized from 0.22 μm filtered solution in PBS ( pH 7.4). Normally 5 % trehalose is added as protectant before lyophilization.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- The lyophilized protein is stable for at least 2 years from date of receipt at -20° C.
-
Haltbarkeit
- 24 months
-
-
- CD226
-
Andere Bezeichnung
- CD226 molecule
-
Hintergrund
- CD226 Molecule, CD226, DNAM1, PTA1, TLiSA1
-
Molekulargewicht
- 50-70 kDa
-
UniProt
- Q15762
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
Target
-